Ugo Perricone

Dr. Ugo Perricone

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2017 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
MWMarcus Wieder
Marcus Wieder
AGArthur Garon
Arthur Garon
UPUgo Perricone
Ugo Perricone
SBStefan Boresch
Stefan Boresch
TSThomas Seidel
Thomas Seidel
TLThierry Langer
Thierry Langer

14 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Stella CascioferroStella Cascioferro
Stella Cascioferro
GPGiovanna Li Petri
Giovanna Li Petri
BPBarbara Parrino
Barbara Parrino
BHBtissame El Hassouni
Btissame El Hassouni
Daniela CarboneDaniela Carbone
Daniela Carbone
PDPatrizia Diana
Patrizia Diana
A new series of imidazo[2,1-b][1,3,4]thiadiazole derivatives was efficiently synthesized and screened for their in vitro antiproliferative activity on a panel of pancreatic ductal adenocarcinoma (PDAC) cells, including SUIT-2, Capan-1 and Panc-1. Compounds 9c and 9l, showed relevant in vitro antiproliferative activity on all three pre-clinical models with half maximal inhibitory concentration (IC50) ranging from 5.11 to 10.8 µM, while the compounds 9e and 9n were active in at least one cell line. In addition, compound 9c significantly inhibited the migration rate of SUIT-2 and Capan-1 cells in the scratch wound-healing assay. In conclusion, our results will support further studies to increase the library of imidazo [2,1-b][1,3,4] thiadiazole derivatives for deeper understanding of the relationship between biological activity of the compounds and their structures in the development of new antitumor compounds against pancreatic diseases.

19 April 2018 in MedChemComm
Verified
Journal Article
Closed access
PDF file
UPUgo Perricone
Ugo Perricone
MGMaria Rita Gulotta
Maria Rita Gulotta
JLJessica Lombino
Jessica Lombino
BPBarbara Parrino
Barbara Parrino
Stella CascioferroStella Cascioferro
Stella Cascioferro
APAlessandro Padova
Alessandro Padova
Molecular dynamics has been demonstrated to be crucial for unveiling otherwise hidden binding sites especially for the undruggable target challenge.

1 January 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMAnnamaria Martorana
Annamaria Martorana
Carla GentileCarla Gentile
Carla Gentile
UPUgo Perricone
Ugo Perricone
Antonio Palumbo PiccionelloAntonio Palumbo Piccionello
Antonio Palumbo Piccionello
RBRoberta Bartolotta
Roberta Bartolotta
ALAntonino Lauria
Antonino Lauria

8 September 2020 in Computation
Verified
Journal Article
Open access
PDF file
GCGiulia Culletta
Giulia Culletta
MGMaria Rita Gulotta
Maria Rita Gulotta
UPUgo Perricone
Ugo Perricone
MZMaria Zappalà
Maria Zappalà
AAAnna Maria Almerico
Anna Maria Almerico
Marco TutoneMarco Tutone
Marco Tutone
To date, SARS-CoV-2 infectious disease, named COVID-19 by the World Health Organization (WHO) in February 2020, has caused millions of infections and hundreds of thousands of deaths. Despite the scientific community efforts, there are currently no approved therapies for treating this coronavirus infection. The process of new drug development is expensive and time-consuming, so that drug repurposing may be the ideal solution to fight the pandemic. In this paper, we selected the proteins encoded by SARS-CoV-2 and using homology modeling we identified the high-quality model of proteins. A structure-based pharmacophore modeling study was performed to identify the pharmacophore features for each target. The pharmacophore models were then used to perform a virtual screening against the DrugBank library (investigational, approved and experimental drugs). Potential inhibitors were identified for each target using XP docking and induced fit docking. MM-GBSA was also performed to better prioritize potential inhibitors. This study will provide new important comprehension of the crucial binding hot spots usable for further studies on COVID-19. Our results can be used to guide supervised virtual screening of large commercially available libraries.

1 February 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MWMarcus Wieder
Marcus Wieder
UPUgo Perricone
Ugo Perricone
SBStefan Boresch
Stefan Boresch
TSThomas Seidel
Thomas Seidel
TLThierry Langer
Thierry Langer